Integrated BioPharma, Inc. (NASDAQ:INBP) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Headlines Articles Press releases Integrated BioPharma, Inc.

Home
Companies
Integrated BioPharma, Inc.

BRIEF

published on 11/13/2024 at 23:38, 7 days 14 hours ago

Integrated BioPharma, Inc. Announces Q3 2024 Financial Results

Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
PRESS RELEASE

published on 11/13/2024 at 23:33, 7 days 14 hours ago

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
Integrated BioPharma, Inc. reports revenue growth in Q3 2024 with net income of $0.3 million. Diversification of customer base leads to increased financial performance

Revenue Growth Financial Performance Diversification Q3 2024 Integrated BioPharma
BRIEF

published on 09/20/2024 at 23:45, 2 months ago

Integrated BioPharma Announces Financial Results for Quarter and Fiscal Year Ended June 30, 2024

Financial Results Revenue Net Income Operating Income Integrated BioPharma
PRESS RELEASE

published on 09/20/2024 at 23:40, 2 months ago

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Integrated BioPharma, Inc. reports financial results with minor revenue decrease. Emphasis on core businesses for growth and diversification of customer base

Financial Results Revenue Decrease Customer Base Integrated BioPharma Core Businesses
BRIEF

published on 05/10/2024 at 22:35, 6 months 10 days ago

Integrated BioPharma Releases Financial Results for Q1 2024

Financial Results Quarterly Report Operating Income Revenue Stability Integrated BioPharma
PRESS RELEASE

published on 05/10/2024 at 22:30, 6 months 10 days ago

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Integrated BioPharma, Inc. reports financial results for Q1 2024, showing stable revenue and net income compared to Q1 2023. The company aims to reduce reliance on key customers. Details and future outlook provided

Financial Results Revenue Net Income Integrated BioPharma Inc. Customer Base
PRESS RELEASE

published on 02/12/2024 at 22:25, 9 months 8 days ago

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
Integrated BioPharma, Inc. reports financial results for the quarters and six-month periods ended December 31, 2023 and 2022, with revenue, operating losses, and net loss figures outlined

Financial Results Revenue Integrated BioPharma Inc. Operating Losses Net Loss
PRESS RELEASE

published on 11/09/2023 at 20:15, 1 year ago

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
PRESS RELEASE

published on 09/15/2023 at 22:30, 1 year 2 months ago

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
PRESS RELEASE

published on 05/11/2023 at 21:30, 1 year 6 months ago

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

Accesswire

Published on 11/21/2024 at 13:30, 21 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 21 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 51 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 51 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 51 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 36 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 15 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 36 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 44 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 51 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 31 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE